Amanda L Kong, MD, MS, FACS | Medical College of Wisconsin

Amanda L. Kong, MD, MS, FACS

Associate Professor; Chief, Section of Breast Surgery

view physician profile

Locations

Froedtert Hospital
Breast Care Center - Froedtert
Mequon Health Center

Specialties

Surgical Oncology
General Surgery

Languages

French, English

Secondary Appointments

General Surgery

Contact Information

Education

MD - Doctor of Medicine
MS -Master of Science
FACS - Fellow in the American College of Surgeons

Research Interests

Dr. Kong is a breast surgical oncologist with a clinical and research focus in breast cancer and benign breast diseases. She joined the CAPS group (formerly known as PCOR) while completing her Master’s Degree in Epidemiology at the Medical College of Wisconsin. Her clinical practice provides the foundation for her research to help improve the care of her patients. She has an interest in quality of care and health care disparities with respect to breast cancer outcomes. Her current research focuses on the relationship between hospital volume and breast cancer care, including differences in processes of care in high- and low-volume hospitals and their impact on mortality through the use of large administrative databases and tumor registries.

Improving Communication in Breast Cancer Treatment Consultation: Use of a Computer Test of Health Numeracy.

(Schapira MM, Fletcher KE, Ganschow PS, Jacobs EA, Walker CM, Smallwood AJ, Gil D, Faghri A, Kong AL, Yen TW, McDunn S, Marcus E, Neuner JM.) J Womens Health (Larchmt). 2019 Oct;28(10):1407-1417.
Surgery in the Older Patient with Breast Cancer.

(Frebault J, Bergom C, Kong AL.) Curr Oncol Rep. 2019 Jun 25;21(8):69.
Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.

(Ferrigni E, Bergom C, Yin Z, Szabo A, Kong AL.) Clin Breast Cancer. 2019 Jun;19(3):157-164.
Discussion of preoperative mammography in women undergoing reduction mammaplasty.

(Klement KA, Hijjawi JB, Neuner J, Kelley K, Kong AL.) Breast J. 2019 05;25(3):439-443.
The association of socioeconomic status with receipt of neoadjuvant chemotherapy.

(Neuner JM, Kong A, Blaes A, Riley D, Chrischilles E, Smallwood A, Lizarraga I, Schroeder M.) Breast Cancer Res Treat. 2019 Jan;173(1):179-188.
Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations.

(Currey A, Patten CR, Bergom C, Wilson JF, Kong AL.) Breast J. 2018 11;24(6):902-910.
The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer.

(Kong AL, Nattinger AB, McGinley E, Pezzin LE.) Breast Cancer Res Treat. 2018 Sep;171(2):477-488.
Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.

(Jin Y, Hu W, Liu T, Rana U, Aguilera-Barrantes I, Kong A, Kumar SN, Wang B, Gao P, Wang X, Duan Y, Shi A, Song D, Yang M, Li S, Han B, Zhao G, Fan Z, Miao QR.) Cancer Lett. 2018 04 10;419:233-244.
Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy.

(Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA.) J Cancer Surviv. 2018 04;12(2):268-275.
Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.

(Quryshi N, Norwood Toro LE, Ait-Aissa K, Kong A, Beyer AM.) Int J Mol Sci. 2018 Mar 10;19(3).
Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?

(Chaudhary LN, Wilkinson KH, Kong A.) Surg Oncol Clin N Am. 2018 01;27(1):141-153.
Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

(Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL.) Am J Surg. 2016 Oct;212(4):660-669.